World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
47338
World Ranking
5539
National Ranking
2989

Klaus J. Busam publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Klaus J. Busam sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 563 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Klaus J. Busam D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Klaus J. Busam sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Klaus J. Busam is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a marked focus on oncology and molecular biology subfields.

Their work encompasses key areas including cutaneous melanoma detection and management, melanoma and MAPK pathways, cancer genomics and diagnostics, immunotherapy and immune responses, nonmelanoma skin cancer studies, cancer and skin lesions, as well as CAR-T cell therapy research.

Frequent publication venues for Klaus J. Busam include:

  • Journal of Surgical Oncology
  • UNC Libraries
  • Journal of Cutaneous Pathology
  • The American Journal of Surgical Pathology
  • Modern Pathology

Their recent papers reflect ongoing research in melanoma and pathology. Notable recent publications include:

  • Neoadjuvant relatlimab and nivolumab in resectable melanoma, 2022, Nature
  • Validation of a digital pathology system including remote review during the COVID-19 pandemic, 2020, Modern Pathology
  • Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors, 2020, The American Journal of Surgical Pathology
  • Use of Ultrasmall Core-Shell Fluorescent Silica Nanoparticles for Image-Guided Sentinel Lymph Node Biopsy in Head and Neck Melanoma, 2021, JAMA Network Open
  • PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions, 2021, Surgical Pathology Clinics

Klaus J. Busam has collaborated frequently with researchers including Marianne Berwick, Irene Orlow, Nancy E. Thomas, Colin B. Begg, and David P. Winchester.

In addition to articles, Klaus J. Busam has contributed to book publications such as Melanocytic Tumors of the Skin, published in 2024 by the American Registry of Pathology Arlington, Virginia eBooks.

Best Publications

  • Distinct Sets of Genetic Alterations in Melanoma

    John A. Curtin;Jane Fridlyand;Toshiro Kageshita;Hetal N. Patel

  • Somatic Activation of KIT in Distinct Subtypes of Melanoma

    John A. Curtin;Klaus Busam;Daniel Pinkel;Boris C. Bastian

  • Clinical-grade computational pathology using weakly supervised deep learning on whole slide images.

    Gabriele S.V. Campanella;Gabriele S.V. Campanella;Matthew G. Hanna;Luke Geneslaw;Allen Miraflor

  • Mutations in GNA11 in Uveal Melanoma

    Catherine D Van Raamsdonk;Klaus G Griewank;Michelle B Crosby;Maria C Garrido

  • KIT as a therapeutic target in metastatic melanoma

    Richard D. Carvajal;Cristina R. Antonescu;Jedd D. Wolchok;Paul B. Chapman

  • Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution

    Peter J. Allen;Wilbur B. Bowne;David P. Jaques;Murray F. Brennan

  • A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

    Guido Rindi;David S. Klimstra;Behnoush Abedi-Ardekani;Sylvia L. Asa

  • Determinants of BRAF Mutations in Primary Melanomas

    Janet L. Maldonado;Jane Fridlyand;Hetal Patel;Ajay N. Jain

  • Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues

    Achim A. Jungbluth;Yao-Tseng Chen;Elisabeth Stockert;Klaus J. Busam

  • Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.

    Thomas Wiesner;Jie He;Roman Yelensky;Rosaura Esteve-Puig

  • Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225.

    K.J. Busam;P. Capodieci;R. Motzer;T. Kiehn

  • Primary mucosal malignant melanoma of the head and neck.

    Snehal G. Patel;Manju L. Prasad;Margarita Escrig;Bhuvanesh Singh

  • Dermatologic side effects associated with the epidermal growth factor receptor inhibitors

    Anna Liza C. Agero;Stephen W. Dusza;Cristiane Benvenuto-Andrade;Klaus J. Busam

  • Guidelines of care for the management of cutaneous squamous cell carcinoma

    Murad Alam;April Armstrong;Christian Baum;Jeremy S. Bordeaux

  • Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.

    Nora Pencheva;Hien Tran;Colin Buss;Doowon Huh

  • Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor.

    V.R. Belum;B. Benhuri;B. Benhuri;M.A. Postow;M.A. Postow;M.D. Hellmann;M.D. Hellmann

  • Tumor-Infiltrating Lymphocytes Predict Sentinel Lymph Node Positivity in Patients With Cutaneous Melanoma

    Rebecca C. Taylor;Ami Patel;Katherine S. Panageas;Klaus J. Busam

  • PRAME Expression in Melanocytic Tumors

    Cecilia Lezcano;Achim A. Jungbluth;Kishwer S. Nehal;Travis J. Hollmann

  • Analysis of BRAF and N-RAS Mutations in Metastatic Melanoma Tissues

    Alexis Gorden;Iman Osman;Weiming Gai;Dan He

  • A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.

    Achim A. Jungbluth;Klaus J. Busam;William L. Gerald;Elisabeth Stockert

Frequent Co-Authors

Ashfaq A. Marghoob
Ashfaq A. Marghoob Memorial Sloan Kettering Cancer Center
Achim A. Jungbluth
Achim A. Jungbluth Memorial Sloan Kettering Cancer Center
Richard A. Scolyer
Richard A. Scolyer Royal Prince Alfred Hospital
Daniel G. Coit
Daniel G. Coit Memorial Sloan Kettering Cancer Center
Marianne Berwick
Marianne Berwick University of New Mexico
Allan C. Halpern
Allan C. Halpern Memorial Sloan Kettering Cancer Center
Colin B. Begg
Colin B. Begg Memorial Sloan Kettering Cancer Center
Mario E. Lacouture
Mario E. Lacouture Memorial Sloan Kettering Cancer Center
Jedd D. Wolchok
Jedd D. Wolchok Cornell University
Irene Orlow
Irene Orlow Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA can lead to a variety of rewarding career options, including alternative healthcare pathways and supporting roles. Many students look for quicker or more flexible degree options to enter the healthcare industry. For those interested in nursing without a prior nursing background, online MSN programs for non nurses offer direct-entry routes to a Master’s of Science in Nursing.

Getting accepted into a nursing program can be competitive, but some might appreciate discovering what is the easiest nursing program to get into for a less complicated admission process. Financial factors are also a key concern—prospective students in medical administration may benefit from learning about medical billing and coding financial aid.

Admission exams can be another hurdle for nursing hopefuls. Fortunately, it’s possible to find nursing schools that don't require teas or hesi, making the application process less stressful. Exploring these varied educational and career pathways can help you find the best route into the medical field based on your background, goals, and needs.

Best Scientists Citing Klaus J. Busam

Trending Scientists

Recently Published Articles